Historique
Article de Périodique
Primary care-relevant interventions for tobacco use prevention and cessation in children and adolescents: A systematic evidence review for the U.S. preventive services task force (2013)
Auteur(s) :
PATNODE, C. D. ;
O'CONNOR, E. ;
WHITLOCK, E. P. ;
PERDUE, L. A. ;
SOH, C. ;
HOLLIS, J.
Année
2013
Page(s) :
253-260
Sous-type de document :
Revue de presse / Press review
Langue(s) :
Anglais
Refs biblio. :
42
Domaine :
Tabac / Tobacco / e-cigarette
Thésaurus géographique
ETATS-UNIS
Thésaurus mots-clés
TABAC
;
PREVENTION
;
ENFANT
;
ADOLESCENT
;
SEVRAGE
;
INITIATION
;
INTERVENTION
;
BUPROPION
Résumé :
Background: Interventions to prevent smoking uptake or encourage cessation among young persons might help prevent tobacco-related illness.
Purpose: To review the evidence for the efficacy and harms of primary care-relevant interventions that aim to reduce tobacco use among children and adolescents.
Data Sources: Three systematic reviews that collectively covered the relevant literature; MEDLINE, PsycINFO, the Cochrane Central Register of Controlled Trials, and the Database of Abstracts of Reviews of Effects through 14 September 2012; and manual searches of reference lists and gray literature.
Study Selection: Two investigators independently reviewed 2453 abstracts and 111 full-text articles. English-language trials of behavior-based or medication interventions that were relevant to primary care and reported tobacco use, health outcomes, or harms were included.
Data Extraction: One investigator abstracted data from good- and fair-quality trials into an evidence table, and a second checked these data.
Data Synthesis: 19 trials (4 good-quality and 15 fair-quality) that were designed to prevent tobacco use initiation or promote cessation (or both) and reported self-reported smoking status or harms were included. Pooled analyses from a random-effects meta-analysis suggested a 19% relative reduction (risk ratio, 0.81 [95% CI, 0.70 to 0.93]; absolute risk difference, -0.02 [CI, -0.03 to 0.00]) in smoking initiation among participants in behavior-based prevention interventions compared with control participants. Neither behavior-based nor bupropion cessation interventions improved cessation rates. Findings about the harms related to bupropion use were mixed.
Limitations: No studies reported health outcomes. Interventions and measures were heterogeneous. Most trials examined only cigarette smoking. The body of evidence was largely published 5 to 15 years ago.
Conclusion: Primary care-relevant interventions may prevent smoking initiation over 12 months in children and adolescents.
Primary Funding Source: Agency for Healthcare Research and Quality.
Purpose: To review the evidence for the efficacy and harms of primary care-relevant interventions that aim to reduce tobacco use among children and adolescents.
Data Sources: Three systematic reviews that collectively covered the relevant literature; MEDLINE, PsycINFO, the Cochrane Central Register of Controlled Trials, and the Database of Abstracts of Reviews of Effects through 14 September 2012; and manual searches of reference lists and gray literature.
Study Selection: Two investigators independently reviewed 2453 abstracts and 111 full-text articles. English-language trials of behavior-based or medication interventions that were relevant to primary care and reported tobacco use, health outcomes, or harms were included.
Data Extraction: One investigator abstracted data from good- and fair-quality trials into an evidence table, and a second checked these data.
Data Synthesis: 19 trials (4 good-quality and 15 fair-quality) that were designed to prevent tobacco use initiation or promote cessation (or both) and reported self-reported smoking status or harms were included. Pooled analyses from a random-effects meta-analysis suggested a 19% relative reduction (risk ratio, 0.81 [95% CI, 0.70 to 0.93]; absolute risk difference, -0.02 [CI, -0.03 to 0.00]) in smoking initiation among participants in behavior-based prevention interventions compared with control participants. Neither behavior-based nor bupropion cessation interventions improved cessation rates. Findings about the harms related to bupropion use were mixed.
Limitations: No studies reported health outcomes. Interventions and measures were heterogeneous. Most trials examined only cigarette smoking. The body of evidence was largely published 5 to 15 years ago.
Conclusion: Primary care-relevant interventions may prevent smoking initiation over 12 months in children and adolescents.
Primary Funding Source: Agency for Healthcare Research and Quality.
Affiliation :
Oregon Evidence-based Practice Center, Portland, Oregon, USA